For the Inventor, By the Inventor

Enter assignee name

Boulder, CO, United States of America

Somatogen, Inc.

USPTO Granted Patents = 24

CIPO Patents = 1

Forward Citations = 338

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

David C Anderson (10 out of 45 patents)

Stephen J Hoffman (9 out of 11 patents)

Antony James Mathews (9 out of 17 patents)

4. Kiyoshi Nagai (8 out of 13 patents)

5. Gary L Stetler (8 out of 9 patents)

6. Douglas L Looker (7 out of 14 patents)

7. Michael Wagenbach (4 out of 4 patents)

8. Mary S Rosendahl (3 out of 18 patents)

9. Michael J Gerber (3 out of 21 patents)

10. Izydor Z Apostol (2 out of 5 patents)

11. Spencer J Anthony-Cahill (2 out of 4 patents)

12. Joseph D Levine (2 out of 3 patents)

13. Jacqueline F Aitken (2 out of 2 patents)

14. Julie A Lippincott (2 out of 2 patents)

15. Maura-Ann H Matthews (2 out of 3 patents)

24 patents: Sort by Forward Citations

1. 6274331 - Method of determining a functional linker for fusing globin subunts (2001-08-14),

2. 6242417 - Stabilized compositions containing hemoglobin (2001-06-05),

3. 6140071 - Proteins with mutations to decrease N-terminal methylation (2000-10-31),

4. 5844090 - Modified hemoglobin-like compounds (1998-12-01),

5. 5844089 - Genetically fused globin-like polypeptides having hemoglobin-like (1998-12-01),

6. 5844088 - Hemoglobin-like protein comprising genetically fused globin-like (1998-12-01),

7. 5811264 - Proteins with mutations to decrease N-terminal methylation (1998-09-22),

8. 5801019 - DNA encoding fused alpha-beta globin pseuodimer and production of (1998-09-01),

9. 5798227 - Co-expression of alpha and beta globins (1998-08-25),

10. 5776890 - Hemoglobins with intersubunit disulfide bonds (1998-07-07),

11. 5759517 - Hemoglobins as drug delivery agents (1998-06-02),

12. 5750132 - Treatment of adverse effects associated with administration of (1998-05-12),

13. 5744329 - DNA encoding fused di-beta globins and production of pseudotetrameric (1998-04-28),

14. 5739011 - DNA for the production of multimeric hemoglobins (1998-04-14),

15. 5717058 - Peptide inhibitors of tax-dependent transcription (1998-02-10),

Somatogen, Inc. is a biotechnology company based in Boulder, Colorado, specializing in the development of innovative therapies for the treatment of various medical conditions. The company focuses on harnessing advanced protein engineering and drug delivery technologies to create novel therapeutic solutions. With a commitment to improving patient outcomes, Somatogen aims to address unmet medical needs through its cutting-edge research and development efforts in the biopharmaceutical sector.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

24 Patents

#56 in Boulder, CO

#275 in Colorado

#13,859 in US

#26,595 in the World

Boulder, CO, United States of America

Somatogen, Inc.

Forward Citations = 338

25 inventors:

David C Anderson (10 out of 45 patents)

Stephen J Hoffman (9 out of 11 patents)

Antony James Mathews (9 out of 17 patents)

4. Kiyoshi Nagai (8 out of 13 patents)

5. Gary L Stetler (8 out of 9 patents)

Please report any incorrect information to [email protected]

Loading…